Printer Friendly

Pulmatrix Inc prices public offering at USD0.17 per share.

M2 EQUITYBITES-January 29, 2019-Pulmatrix Inc prices public offering at USD0.17 per share

(C)2019 M2 COMMUNICATIONS http://www.m2.com

Biopharmaceutical company Pulmatrix Inc (NASDAQ:PULM) said on Monday that it has priced its underwritten public offering of 1,561,177 shares of its common stock.

Under the public offering, the company issued 1,561,177 common stock at a price of USD0.17 per share for aggregate gross proceeds of approximately USD265,400.

Net proceeds from the public offering may be used by the company for working capital as well as general corporate purposes.

The offering is expected to close on or about 31 January 2019, subject to customary closing conditions. HC Wainwright & Co is acting as the sole book-running manager.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Jan 29, 2019
Words:134
Previous Article:Renault-Nissan India signs contract with National Skill Development.
Next Article:Innovent Biologics Inc submits NDA for biosimilar product candidate of bevacizumab with the NMPA for multiple types of malignant tumors.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters